Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
LE

Luke A. Esposito — 7 Patents

PRProteometech: 6 patents #9 of 39Top 25%
Seattle, WA: #4,313 of 21,776 inventorsTop 20%
Washington: #14,787 of 76,902 inventorsTop 20%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Luke A. Esposito has been granted 7 US patents while listed as an inventor at Proteometech. The first was granted in 2011 and the most recent in May 2016. Luke A. Esposito ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Luke A. Esposito in Seattle, WA, US.

Patents per Year

Patents granted per year, 2011 to 2016Bar chart with a peak of 3 patents in 2014.peak 32011: 1 patents20112013: 1 patents20132014: 3 patents20142015: 1 patents20152016: 1 patents2016

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
9334251 Compounds for the treatment of neurodegenerative diseases Marisa C. Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu +2 more 2016-05-10
9169255 Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies Kelsey Hanson, Marisa C. Yadon, Thomas Lake, Alan D. Snow, Joel Cummings +1 more 2015-10-27
8916598 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow 2014-12-23
8865754 Compounds for the treatment of neurodegenerative diseases Marisa C. Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Franz F. Hefti +6 more 2014-10-21
8829198 Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow +1 more 2014-09-09
8592476 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow +1 more 2013-11-26
7919530 Compounds, compositions, and methods for the treatment of synucleinopathies Joel Cummings, F. Michael Hudson, Alan D. Snow 2011-04-05